| The role of cholesterol in cancer OF Kuzu, MA Noory, GP Robertson Cancer research 76 (8), 2063-2070, 2016 | 577 | 2016 |
| IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling X Sheng, HZ Nenseth, S Qu, OF Kuzu, T Frahnow, L Simon, S Greene, ... Nature communications 10 (1), 323, 2019 | 184 | 2019 |
| Current state of animal (mouse) modeling in melanoma research OF Kuzu, FD Nguyen, MA Noory, A Sharma Cancer growth and metastasis 8, CGM. S21214, 2015 | 132 | 2015 |
| Effect of lysosomotropic molecules on cellular homeostasis OF Kuzu, M Toprak, MA Noory, GP Robertson Pharmacological research 117, 177-184, 2017 | 82 | 2017 |
| Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport OF Kuzu, R Gowda, A Sharma, GP Robertson Molecular cancer therapeutics 13 (7), 1690-1703, 2014 | 76 | 2014 |
| Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer N Pällmann, M Livgård, M Tesikova, H Zeynep Nenseth, E Akkus, ... Oncogene 38 (35), 6301-6318, 2019 | 63 | 2019 |
| Modulating cancer cell survival by targeting intracellular cholesterol transport OF Kuzu, R Gowda, MA Noory, GP Robertson British journal of cancer 117 (4), 513-524, 2017 | 62 | 2017 |
| Targeting multiple key signaling pathways in melanoma using leelamine R Gowda, SRV Madhunapantula, OF Kuzu, A Sharma, GP Robertson Molecular cancer therapeutics 13 (7), 1679-1689, 2014 | 53 | 2014 |
| Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport R Gowda, GS Inamdar, O Kuzu, SS Dinavahi, J Krzeminski, MB Battu, ... Oncotarget 8 (17), 28260, 2017 | 27 | 2017 |
| Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma R Gowda, SRV Madhunapantula, A Sharma, OF Kuzu, GP Robertson Molecular cancer therapeutics 13 (10), 2328-2340, 2014 | 24 | 2014 |
| A non-cytotoxic N-dehydroabietylamine derivative with potent antimalarial activity MP Sadashiva, R Gowda, X Wu, GS Inamdar, OF Kuzu, KS Rangappa, ... Experimental parasitology 155, 68-73, 2015 | 20 | 2015 |
| Clinical and genomic characteristics of LAMA2 related congenital muscular dystrophy in a patients’ cohort from Qatar. A population specific founder variant AA Aleem, MF Elsaid, N Chalhoub, A Chakroun, KAS Mohamed, ... Neuromuscular Disorders 30 (6), 457-471, 2020 | 17 | 2020 |
| Identification of WEE1 as a target to make AKT inhibition more effective in melanoma OF Kuzu, R Gowda, A Sharma, MA Noory, G Kardos, ... Cancer Biology & Therapy 19 (1), 53-62, 2018 | 16 | 2018 |
| Improving pharmacological targeting of AKT in melanoma OF Kuzu, R Gowda, A Sharma, MA Noory, SS Dinavahi, G Kardos, ... Cancer Letters 404, 29-36, 2017 | 16 | 2017 |
| Compositions and methods relating to proliferative diseases GP Robertson, SRV Madhunapantula, GS Inamdar, OF Kuzu US Patent 9,556,101, 2017 | 16 | 2017 |
| Stress-mediated reprogramming of prostate cancer one-carbon cycle drives disease progression N Pällmann, K Deng, M Livgård, M Tesikova, Y Jin, NS Frengen, ... Cancer research 81 (15), 4066-4078, 2021 | 15 | 2021 |
| STAMP2 expression mediated by cytokines attenuates their growth-limiting effects in prostate cancer cells N Pihlstrøm, Y Jin, Z Nenseth, OF Kuzu, F Saatcioglu Cancers 13 (7), 1579, 2021 | 9 | 2021 |
| Compositions and methods relating to proliferative diseases GP Robertson, CD Raghavendragowda, SRV Madhunapantula, OF Kuzu, ... US Patent 8,785,502, 2014 | 8 | 2014 |
| Natural occurring leelamine inhibits melanoma development by targeting multiple signaling pathways. R Gowda, SRV Madhunapantula, OF Kuzu, A Sharma, RP Gavin Cancer Research 73 (8_Supplement), 5509-5509, 2013 | 3 | 2013 |
| Targeting IRE1α alleviates the immunosuppressive tumor microenvironment in prostate cancer B Unal, OF Kuzu, Y Jin, DC Hurtado, ML Kuijjer, M Daugaard, HZ Oo, ... Cancer Research 84 (6_Supplement), 5362-5362, 2024 | | 2024 |
Mohammad Anwar NooryPostdoct, Penn State College of MedicineVerified email at hmc.psu.edu
